Write a 100-350 word essay about the enzyme human HEXB. Provide information related to enzyme: i) function, ii) reaction pathways, ii) Location, and iv) diseases. In writing include these four subheadings

### Function
Human HEXB, or beta-hexosaminidase B, is an enzyme crucial for the degradation of glycosaminoglycans (GAGs) and glycolipids in lysosomes. HEXB catalyzes the hydrolysis of terminal N-acetylglucosamine and N-acetylgalactosamine residues from these substrates, facilitating their breakdown and recycling. The enzyme functions as a dimer, composed of two beta subunits, and is essential for the proper catabolism of complex molecules, particularly within the central nervous system.

### Reaction Pathways
HEXB operates within the lysosomal degradation pathway, specifically targeting GAGs and glycolipids, including GM2 gangliosides. The enzyme removes N-acetylhexosamines from these substrates, which is a critical step in their catabolism. Without this step, partially degraded molecules would accumulate within lysosomes, leading to cellular dysfunction. HEXB works alongside its isoenzyme, beta-hexosaminidase A (HEXA), to ensure the complete breakdown of these complex molecules.

### Location
HEXB is localized in the lysosomes, the cellular organelles responsible for breaking down and recycling various biomolecules. The enzymeâ€™s presence in the lysosome is essential for its role in degrading glycolipids and glycosaminoglycans, preventing their accumulation within cells. This lysosomal localization allows HEXB to interact directly with its substrates, ensuring efficient catabolism of these molecules.

### Diseases
Mutations in the HEXB gene lead to Sandhoff disease, a lysosomal storage disorder similar to Tay-Sachs disease. Sandhoff disease is characterized by the accumulation of GM2 gangliosides and other glycolipids in neurons, resulting in progressive neurodegeneration, muscle weakness, and developmental delays. The disease typically presents in infancy and progresses rapidly, leading to severe neurological impairment and early death. HEXB deficiency disrupts the breakdown of GM2 gangliosides, causing toxic accumulation within lysosomes and subsequent neuronal damage. Understanding the role of HEXB is critical for developing potential therapies for Sandhoff disease and related lysosomal storage disorders.